Entering text into the input field will update the search result below

IRIDEX Corporation (IRIX) CEO William Moore on Q2 2018 Results - Earnings Call Transcript

Aug. 05, 2018 11:35 AM ETIRIDEX Corporation (IRIX)
SA Transcripts profile picture
SA Transcripts

IRIDEX Corporation (NASDAQ:IRIX) Q2 2018 Earnings Conference Call August 2, 2018 5:00 PM ET


Leigh Salvo - Head of Investor Relations

William Moore - Chairman, President and Chief Executive Officer

Atabak Mokari - Chief Financial Officer and Vice President of Corporate Development


Scott Henry - Roth Capital Partners

Larry Haimovitch - HMTC


Good day, ladies and gentlemen, and welcome to the Q2 2018 IRIDEX Earnings Conference Call. At this time, all participants are in a listen-only mode. Following management's prepared remarks, we will have a question-and-answer session and instructions will be given at that time. [Operator Instructions]. As a reminder, today's conference is being recorded for replay purposes.

It is now my pleasure to turn the conference over to your host Leigh Salvo, Head of Investor Relations. Please go ahead.

Leigh Salvo

Thank you. And thank you all for participating in today's call. Joining me are Will Moore, Chief Executive Officer; and Atabak Mokari, Chief Financial Officer. Earlier today, IRIDEX released financial results for the quarter ended June 30, 2018. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements made during this call that are not statements of historical fact, including but not limited to statements concerning our strategic goals and priorities; product development matters; sales and marketing matters including our presence at future industry events; sales trends, including our ability to secure orders from hospitals, clinics and ambulatory surgery centers; the markets in which we operate, including South Korea and China; the recall of our LIO product, its impact on our business and results on our plans to return

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.